Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Galena Management Criticized
By:
MarketMinute.com Stock News
Posted on November 12, 2012 at 17:08 PM EST
PropThink wrote that the management team at Galena Biopharma (
Nasdaq: GALE
) was incompetent and that the biotechnology company reported inaccurate clinical trial results sending the stock price tumbling 63 cents to close at $1.40.
Related Stocks:
GALENA BIOPHARMA
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here